Company / PP&E per Share
Tandem Diabetes Care PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.26
FY2025
5-year range
$0.81 / $1.26
FY2021-FY2025
Trend
+5.8%
vs FY2024
Sector context
#93 of 130
Health Care
What the data says
At $1.26, Tandem Diabetes Care's pp&e per share ranks #93 of 130 in the Health Care sector. PP&E per Share has increased for 4 consecutive years, from $0.81 in FY2021 to $1.26 in FY2025.
Based on SEC 10-K filings.
1.26 in FY2025 with a 5-year CAGR of +8.4%.
Improved from $1.19 to $1.26 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#93 of 130 in Health CareTop 72% of 130This company $1.26 Sector average $11.80
▼
-89.3% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's pp&e per share has grown for 4 consecutive years.
- In FY2025, pp&e per share increased 5.8% year-over-year.
- Ranks #93 out of 130 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.26 | +5.8% |
| FY2024 | $1.19 | +0.5% |
| FY2023 | $1.19 | +10.5% |
| FY2022 | $1.07 | +32.9% |
| FY2021 | $0.81 | -4.0% |
| FY2020 | $0.84 | +47.2% |
| FY2019 | $0.57 | -66.3% |
| FY2018 | $1.69 | -73.1% |
| FY2017 | $6.31 | +937.4% |
| FY2016 | $0.61 | -7.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026